Madrigal Prices Upsized Public Offering Of $600 Mln Of Shares
19/3 07:39
(RTTNews) - Madrigal Pharmaceuticals, Inc. (MDGL), a company focused on nonalcoholic steatohepatitis, said that it has priced its upsized public offering of 750,000 shares at $260 per share and pre-funded warrants to purchase 1,557,692 shares at $259.9999 per pre-funded warrant....